Toll Free: 1-888-928-9744

Global and United States Primary Biliary Cirrhosis Drug In-Depth Research Report 2017-2022

Published: Dec, 2017 | Pages: 102 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Primary Biliary Cirrhosis Drug industry.

Major Companies
    AlbireoPharma
    CymaBay Therapeutics, Inc.
    Dr. Falk Pharma GmbH
    Enanta Pharmaceuticals, Inc.
    GlaxoSmithKline Plc
    Intercept Pharmaceuticals, Inc.
    Johnson & Johnson
    MediGene AG
    NGM Biopharmaceuticals, Inc.
    Virobay Inc.

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Primary Biliary Cirrhosis Drug Market, bydesonide
Primary Biliary Cirrhosis Drug Market, byP-104
Primary Biliary Cirrhosis Drug Market, byK-2330672
Primary Biliary Cirrhosis Drug Market, byX-8025
Primary Biliary Cirrhosis Drug Market, byM-282

Primary Biliary Cirrhosis Drug Market, by Key Consumers
    Clinic
    Hospital
    Others

 Table of Contents

Global and United States Primary Biliary Cirrhosis Drug In-Depth Research Report 2017-2022
Chapter One Global Primary Biliary Cirrhosis Drug Market Overview
    1.1 Global Primary Biliary Cirrhosis Drug Market Sales Volume Revenue and Price 2012-2017
    1.2 Primary Biliary Cirrhosis Drug, by esonide 2012-2017
        1.2.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by esonide 2012-2017
        1.2.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by esonide 2012-2017
        1.2.3 Global Primary Biliary Cirrhosis Drug Price by esonide 2012-2017
        1.2.4 
        1.2.5 
    1.3 Primary Biliary Cirrhosis Drug, by -104 2012-2017
        1.3.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by -104 2012-2017
        1.3.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by -104 2012-2017
        1.3.3 Global Primary Biliary Cirrhosis Drug Price by -104 2012-2017
        1.3.4 
        1.3.5 
    1.4 Primary Biliary Cirrhosis Drug, by -2330672 2012-2017
        1.4.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by -2330672 2012-2017
        1.4.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by -2330672 2012-2017
        1.4.3 Global Primary Biliary Cirrhosis Drug Price by -2330672 2012-2017
        1.4.4 
        1.4.5 
    1.5 Primary Biliary Cirrhosis Drug, by -8025 2012-2017
        1.5.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by -8025 2012-2017
        1.5.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by -8025 2012-2017
        1.5.3 Global Primary Biliary Cirrhosis Drug Price by -8025 2012-2017
        1.5.4 
        1.5.5 
    1.6 Primary Biliary Cirrhosis Drug, by -282 2012-2017
        1.6.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by -282 2012-2017
        1.6.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by -282 2012-2017
        1.6.3 Global Primary Biliary Cirrhosis Drug Price by -282 2012-2017
        1.6.4 
        1.6.5 

Chapter Two United States Primary Biliary Cirrhosis Drug Market Overview
    2.1 United States Primary Biliary Cirrhosis Drug Market Sales Volume Revenue and Price 2012-2017
    2.2 Primary Biliary Cirrhosis Drug, by esonide 2012-2017
        2.2.1 United States Primary Biliary Cirrhosis Drug Sales Market Share by esonide 2012-2017
        2.2.2 United States Primary Biliary Cirrhosis Drug Revenue Market Share by esonide 2012-2017
        2.2.3 United States Primary Biliary Cirrhosis Drug Price by esonide 2012-2017
        2.2.4 
        2.2.5 
    2.3 Primary Biliary Cirrhosis Drug, by -104 2012-2017
        2.3.1 United States Primary Biliary Cirrhosis Drug Sales Market Share by -104 2012-2017
        2.3.2 United States Primary Biliary Cirrhosis Drug Revenue Market Share by -104 2012-2017
        2.3.3 United States Primary Biliary Cirrhosis Drug Price by -104 2012-2017
        2.3.4 
        2.3.5 
    2.4 Primary Biliary Cirrhosis Drug, by -2330672 2012-2017
        2.4.1 United States Primary Biliary Cirrhosis Drug Sales Market Share by -2330672 2012-2017
        2.4.2 United States Primary Biliary Cirrhosis Drug Revenue Market Share by -2330672 2012-2017
        2.4.3 United States Primary Biliary Cirrhosis Drug Price by -2330672 2012-2017
        2.4.4 
        2.4.5 
    2.5 Primary Biliary Cirrhosis Drug, by -8025 2012-2017
        2.5.1 United States Primary Biliary Cirrhosis Drug Sales Market Share by -8025 2012-2017
        2.5.2 United States Primary Biliary Cirrhosis Drug Revenue Market Share by -8025 2012-2017
        2.5.3 United States Primary Biliary Cirrhosis Drug Price by -8025 2012-2017
        2.5.4 
        2.5.5 
    2.6 Primary Biliary Cirrhosis Drug, by -282 2012-2017
        2.6.1 United States Primary Biliary Cirrhosis Drug Sales Market Share by -282 2012-2017
        2.6.2 United States Primary Biliary Cirrhosis Drug Revenue Market Share by -282 2012-2017
        2.6.3 United States Primary Biliary Cirrhosis Drug Price by -282 2012-2017
        2.6.4 
        2.6.5 

Chapter Three Primary Biliary Cirrhosis Drug by Regions 2012-2017
    3.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Regions 2012-2017
    3.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Regions 2012-2017
    3.3 Global Primary Biliary Cirrhosis Drug Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Primary Biliary Cirrhosis Drug by Companies 2012-2017
    4.1 Global Primary Biliary Cirrhosis Drug Sales Volume Market Share by Companies 2012-2017
    4.2 Global Primary Biliary Cirrhosis Drug Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Primary Biliary Cirrhosis Drug Key Product Model and Market Performance
    4.4 Global Top Companies Primary Biliary Cirrhosis Drug Key Target Consumers and Market Performance

Chapter Five United States Primary Biliary Cirrhosis Drug by Companies 2012-2017
    5.1 United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Companies 2012-2017
    5.2 United States Primary Biliary Cirrhosis Drug Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Primary Biliary Cirrhosis Drug Key Product Model and Market Performance
    5.4 United States Top Companies Primary Biliary Cirrhosis Drug Key Target Consumers and Market Performance

Chapter Six Global Primary Biliary Cirrhosis Drug by Consumer 2012-2017
    6.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Consumer 2012-2017
    6.2 Clinic
    6.3 Hospital
    6.4 Others
    6.5 Consuming Habit and Preference

Chapter Seven Global Primary Biliary Cirrhosis Drug by Consumer 2012-2017
    7.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Consumer 2012-2017
    7.2 Clinic
    7.3 Hospital
    7.4 Others
    7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 AlbireoPharma
        8.1.1 AlbireoPharma Company Details and Competitors
        8.1.2 AlbireoPharma Key Primary Biliary Cirrhosis Drug Models and Performance
        8.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.1.4 AlbireoPharma Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.2 CymaBay Therapeutics, Inc.
        8.2.1 CymaBay Therapeutics, Inc. Company Details and Competitors
        8.2.2 CymaBay Therapeutics, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
        8.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.2.4 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.3 Dr. Falk Pharma GmbH
        8.3.1 Dr. Falk Pharma GmbH Company Details and Competitors
        8.3.2 Dr. Falk Pharma GmbH Key Primary Biliary Cirrhosis Drug Models and Performance
        8.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.3.4 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.4 Enanta Pharmaceuticals, Inc.
        8.4.1 Enanta Pharmaceuticals, Inc. Company Details and Competitors
        8.4.2 Enanta Pharmaceuticals, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
        8.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.4.4 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.5 GlaxoSmithKline Plc
        8.5.1 GlaxoSmithKline Plc Company Details and Competitors
        8.5.2 GlaxoSmithKline Plc Key Primary Biliary Cirrhosis Drug Models and Performance
        8.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.5.4 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.6 Intercept Pharmaceuticals, Inc.
        8.6.1 Intercept Pharmaceuticals, Inc. Company Details and Competitors
        8.6.2 Intercept Pharmaceuticals, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
        8.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.6.4 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.7 Johnson & Johnson
        8.7.1 Johnson & Johnson Company Details and Competitors
        8.7.2 Johnson & Johnson Key Primary Biliary Cirrhosis Drug Models and Performance
        8.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.7.4 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.8 MediGene AG
        8.8.1 MediGene AG Company Details and Competitors
        8.8.2 MediGene AG Key Primary Biliary Cirrhosis Drug Models and Performance
        8.8.3 MediGene AG Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.8.4 MediGene AG Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.9 NGM Biopharmaceuticals, Inc.
        8.9.1 NGM Biopharmaceuticals, Inc. Company Details and Competitors
        8.9.2 NGM Biopharmaceuticals, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
        8.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.9.4 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin
    8.10 Virobay Inc.
        8.10.1 Virobay Inc. Company Details and Competitors
        8.10.2 Virobay Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
        8.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
        8.10.4 Virobay Inc. Primary Biliary Cirrhosis Drug Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Primary Biliary Cirrhosis Drug Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Primary Biliary Cirrhosis Drug Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Primary Biliary Cirrhosis Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by esonide (2017-2022)
    10.5 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -104 (2017-2022)
    10.6 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -2330672 (2017-2022)
    10.7 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -8025 (2017-2022)
    10.8 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -282 (2017-2022)

Chapter Eleven United States Primary Biliary Cirrhosis Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by esonide (2017-2022)
    11.5 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -104 (2017-2022)
    11.6 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -2330672 (2017-2022)
    11.7 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -8025 (2017-2022)
    11.8 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -282 (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Table Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by esonide (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Market Share by esonide (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by esonide in 2016
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by esonide (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by esonide (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by esonide in 2016
    Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by esonide (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by -104 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Market Share by -104 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by -104 in 2016
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by -104 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by -104 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by -104 in 2016
    Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -104 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by -2330672 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Market Share by -2330672 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by -2330672 in 2016
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by -2330672 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by -2330672 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by -2330672 in 2016
    Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -2330672 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by -8025 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Market Share by -8025 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by -8025 in 2016
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by -8025 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by -8025 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by -8025 in 2016
    Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -8025 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by -282 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Market Share by -282 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by -282 in 2016
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by -282 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by -282 (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by -282 in 2016
    Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -282 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by esonide (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales Market Share by esonide (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by esonide in 2016
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by esonide (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue Market Share by esonide (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by esonide in 2016
    Table United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by esonide (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by -104 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales Market Share by -104 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by -104 in 2016
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by -104 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue Market Share by -104 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by -104 in 2016
    Table United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -104 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by -2330672 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales Market Share by -2330672 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by -2330672 in 2016
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by -2330672 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue Market Share by -2330672 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by -2330672 in 2016
    Table United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -2330672 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by -8025 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales Market Share by -8025 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by -8025 in 2016
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by -8025 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue Market Share by -8025 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by -8025 in 2016
    Table United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -8025 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by -282 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales Market Share by -282 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by -282 in 2016
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by -282 (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue Market Share by -282 (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by -282 in 2016
    Table United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by -282 (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Share by Regions (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by Regions in 2016
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by Regions in 2017
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by Regions (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by Regions in 2016
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by Regions in 2017
    Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Regions (2012-2017)
    Table North America Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table North America Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2012-2017)
    Figure North America Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share by Major Companies 2016
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share by Major Companies 2017
    Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by Major Companies (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by Major Companies 2016
    Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Top Companies 2016
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Top Companies 2017
    Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Revenue Market Share by Top Companies (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by Top Companies 2016
    Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by Consumer (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by Consumer in 2016
    Figure Global Clinic Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Hospital Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by Consumer (2012-2017)
    Figure United States Primary Biliary Cirrhosis Drug Sales Market Share by Consumer in 2016
    Figure United States Clinic Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Hospital Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Others Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table AlbireoPharma Company Details and Competitors
    Table AlbireoPharma Key Primary Biliary Cirrhosis Drug Models and Performance
    Table AlbireoPharma Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table AlbireoPharma Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table CymaBay Therapeutics, Inc. Company Details and Competitors
    Table CymaBay Therapeutics, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
    Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table Dr. Falk Pharma GmbH Company Details and Competitors
    Table Dr. Falk Pharma GmbH Key Primary Biliary Cirrhosis Drug Models and Performance
    Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table Enanta Pharmaceuticals, Inc. Company Details and Competitors
    Table Enanta Pharmaceuticals, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
    Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline Plc Company Details and Competitors
    Table GlaxoSmithKline Plc Key Primary Biliary Cirrhosis Drug Models and Performance
    Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table Intercept Pharmaceuticals, Inc. Company Details and Competitors
    Table Intercept Pharmaceuticals, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
    Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson Company Details and Competitors
    Table Johnson & Johnson Key Primary Biliary Cirrhosis Drug Models and Performance
    Table Johnson & Johnson Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table Johnson & Johnson Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table MediGene AG Company Details and Competitors
    Table MediGene AG Key Primary Biliary Cirrhosis Drug Models and Performance
    Table MediGene AG Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table MediGene AG Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure MediGene AG Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table NGM Biopharmaceuticals, Inc. Company Details and Competitors
    Table NGM Biopharmaceuticals, Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
    Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Table Virobay Inc. Company Details and Competitors
    Table Virobay Inc. Key Primary Biliary Cirrhosis Drug Models and Performance
    Table Virobay Inc. Primary Biliary Cirrhosis Drug Business SWOT Analysis and Forecast
    Table Virobay Inc. Primary Biliary Cirrhosis Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global (2012-2017)
    Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global (2012-2017)
    Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions in 2022
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Application in 2022
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by esonide (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by esonide (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by esonide in 2022
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -104 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -104 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -104 in 2022
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -2330672 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -2330672 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -2330672 in 2022
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -8025 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -8025 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -8025 in 2022
    Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -282 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -282 (2017-2022)
    Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -282 in 2022
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions in 2022
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Application in 2022
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by esonide (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by esonide (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by esonide in 2022
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -104 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -104 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -104 in 2022
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -2330672 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -2330672 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -2330672 in 2022
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -8025 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -8025 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -8025 in 2022
    Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -282 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by -282 (2017-2022)
    Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by -282 in 2022

 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3190
Multi User - US $6380
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify